Retatrutide 10mg

Retatrutide is an experimental medication that acts as a triple agonist targeting GIP, GLP-1, and glucagon receptors. Its effects primarily include significant weight reduction, improved blood glucose control, and enhanced insulin sensitivity. Clinical trials have shown that it can support sustained weight loss in individuals with obesity or type 2 diabetes by reducing appetite and increasing energy expenditure. Common side effects are gastrointestinal in nature, such as nausea, vomiting, diarrhoea, and occasional constipation, which typically lessen over time.